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children and adolescents referred for treatment of PNES 
and in 50 controls. Patients showed elevated baseline res-
piratory rates [t(78) = 3.34, p = .001], with 36/52 (69%) 
of patients [vs. 11/28 (39%) controls] falling above the 
75th percentile (χ2 = 6.7343; df = 1; p = .009). Twenty-
eight (47%) of patients [vs. 4/50 (8%) controls] showed a 
skewed hyperventilation-challenge profile—baseline PCO2 
<36 mmHg, a trough PCO2 ≤ 20 mmHg, or a final PCO2 
<36 mmHg after 15 min of recovery—signaling difficulties 
with CO2 regulation (χ
2 = 19.77; df = 1; p < .001). Chil-
dren and adolescents with PNES present in a state of readi-
ness-for-action characterized by high arousal coupled with 
activation of the respiratory motor system, increases in 
ventilation, and a hyperventilation-challenge profile shifted 
downward from homeostatic range. Breathing interventions 
that target arousal, decrease respiratory rate, and normalize 
ventilation and arterial CO2 may help patients shift brain–
body state and avert PNES episodes.
Abstract Psychogenic non-epileptic seizures (PNES) are 
a common problem in paediatric neurology and psychiatry 
that can best be understood as atypical responses to threat. 
Threats activate the body for action by mediating increases 
in arousal, respiration, and motor readiness. In previous 
studies, a range of cardiac, endocrine, brain-based, atten-
tion-bias, and behavioral measures have been used to dem-
onstrate increases in arousal, vigilance, and motor readiness 
in patients with PNES. The current study uses respiratory 
measures to assess both the motor readiness of the respira-
tory system and the respiratory regulation of CO2. Baseline 
respiratory rates during clinical assessment and arterial 
CO2 levels during the hyperventilation component of rou-
tine video electroencephalogram were documented in 60 
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Introduction
Psychogenic non-epileptic seizures (PNES) is a nonspe-
cific, umbrella category referring to non-epileptic seizures 
that are of presumed emotional or psychological origin, are 
not explained by neurological disease, and are thought to 
reflect abnormal central nervous system functioning [1, 2]. 
PNES are diagnosed following a comprehensive evaluation 
involving a detailed history and negative finding of ictal 
electrical activity on electroencephalogram [either video 
EEG (vEEG) or EEG telemetry] [3]. A limitation of the 
diagnosis is that the neurophysiological mechanisms under-
lying the seizures remain unexplained, whereas the current 
move within neurology and psychiatry is to identify the 
biological mechanisms that underpin different subtypes of 
PNES [4–7].
A growing number of studies have examined the neuro-
physiological characteristics of patients with PNES. Key 
findings include: (1) increased baseline arousal indexed by 
elevated cortisol, elevated heart rate (HR), decreased heart 
rate variability (HRV) [8–10]1; (2) exaggerated neurophysi-
ological responses—lower HRV recovery, increased cortisol 
release, and increased amplitudes of event-related potentials 
(ERPs)—to psychological or physiological stress stimuli [8, 
14, 15]; (3) increased vigilance, and motor readiness to 
respond, to emotional signals [8, 11]; (4) changes in con-
nectivity in resting-state brain networks, with alterations in 
brain circuits mediating emotion regulation and arousal, 
cognitive control, self-referential processing, and motor 
planning and coordination [5]; (5) changes in EEG syn-
chrony, both within cortical brain systems and between cor-
tical and subcortical brain systems [16–19]; (6) arousal-
related impairments in prefrontal cortex function [12, 14]; 
and (7) increased avoidance tendencies to social-threat cues 
[20]. Taken together, these findings suggest that PNES may 
emerge in the context of an upregulated stress system and 
extreme reactivity to psychological or physiological threat 
stimuli.
Threat stimuli prepare the body for action by medi-
ating increases in arousal, respiration, and motor readi-
ness. Increases in ventilation—indexed by breathing 
rate and tidal volume—occur alongside a multitude of 
1 In the earlier studies by Kozlowska et al., children/adolescents with 
PNES made up 51% (n = 29/57) of the samples [10–12]. In the most 
recent study of cortical arousal, children/adolescents with PNES made 
up 56% (n = 32/57) of the sample [13].
other changes. When the breathing exceeds metabolic 
demands—termed hyperventilation (HV)—there is a 
depletion of CO2 stores, a respiratory alkalosis (high 
pH), and biphasic brain response [see Supplemental Text 
Box 1 (online) for a summary of the neurophysiology of 
hyperventilation]. An initial excitatory phase is marked 
by an increase in cortical excitability in widely distrib-
uted networks [21, 22]. A subsequent hypoxic phase, 
mediated by cerebral artery constriction, involves a 
decrease in cortical function [23–25]. This hypoxic phase 
is marked by central symptoms, including: impaired 
mental performance/gaps in memory; dizziness and light-
headedness; visual phenomena (blurred, clouded, or tun-
nel vision; flashing lights; or complete blackout); and 
changes in level of consciousness ranging from disorien-
tation/staring to a complete loss of consciousness (syn-
cope) [23, 26, 27]. The degree of hypoxia is determined 
by, and proportional to, individual variations in cerebral 
artery constriction [28, 29]. Because the developing brain 
is more sensitive to the central effects of HV than the 
adult brain [25, 30], children/adolescents are likely to be 
more vulnerable than adults to HV-induced changes in 
brain function.
In the paediatric literature, PNES secondary to HV have 
been described in case reports since the 1960s [31–45], but 
data from larger cohort studies are sparse. In two Indian 
studies examining the clinical characteristics of youth 
referred to psychological services for functional neuro-
logical symptom disorder, a quarter of the youth presenting 
with PNES experienced HV [6/21 (29%) in one study; 6/25 
(24%) in the other], with or without fainting spells [40, 41]. 
A Hungarian study of PNES during vEEG documented HV 
in 14/75 (18.7%) of child/adolescent patients [46]. In adult 
studies, approximately 70–83% of patients report multi-
ple panic-like symptoms—presumably accompanied by 
increased respiratory rate—during PNES [47, 48]. Taken 
together, the above-described studies suggest that panic-
like symptoms or hyperventilation occur in association 
with some PNES, with some indication that hyperventila-
tion may play a causal role.
The current study used respiratory measures to assess the 
motor readiness of the respiratory system and the respira-
tory regulation of CO2 in children/adolescents referred for 
treatment of PNES and in controls. We hypothesized that, 
compared to controls, patients with PNES would show ele-
vated baseline respiratory rates at clinical assessment and 
aberrant patterns of PCO2 regulation during the hyperven-
tilation component of the vEEG, including (1) lower base-
line resting PCO2 levels, (2) faster drops in PCO2, (3) lower 
PCO2 levels following 5 min of routine hyperventilation 
during the vEEG procedure, and (4) less efficient recov-
eries back to a homeostatic norm (≥36 mmHg) following 
hyperventilation. We also expected that compared to healthy 
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controls, patients with PNES would show elevated baseline 
HR, in line with previous findings [10].
Methods
Participants
In 2011, in a joint Neurology–Psychological Medicine pro-
ject with children/adolescents being assessed for PNES—
The PNES Hyperventilation Study—we added both a 
percutaneous probe to the vEEG to measure PCO2 and a 
biofeedback device (MyCalmBeat) to measure baseline 
respiratory rate and implement breath-control interventions 
[10]. In the present study we report on 60 children/adoles-
cents, recruited from April 2011 to March 2016, who were 
diagnosed and treated for PNES. Four children/adolescents 
were excluded because PCO2 data were not collected, and 
four because PCO2 data were inadequate (technical difficul-
ties or child’s lack of cooperation).
Potential controls were excluded from the study if they 
had a past history of PNES, suffered from, or had a past his-
tory of, panic attacks or hyperventilation, or experienced an 
epileptic seizure during the EEG and were unable to follow 
instructions.
The study was approved by the Sydney Children’s Hospital 
Network Ethics Committee. Participants and their legal guard-
ians provided written informed consent in accordance with the 
National Health and Medical Research Council guidelines.
Procedure
Video EEG
Children/adolescents with PNES underwent a routine vEEG 
as part of their neurological assessments. Psychiatry con-
trols underwent the same procedure as part of their inpatient 
medical workups, epilepsy controls as part of their epilepsy 
treatment, and healthy controls as volunteer participants for 
the study. The procedure (35 min) involved: an eyes-open 
condition (3 min); an eyes-closed condition (2 min); photic 
stimulation (3 min); a 5-min break; and the HV challenge 
itself (5 min of HV and a 15-min recovery period). The full 
10–20 electrode placement plus a single-channel electrocar-
diogram was used. A pulse oximeter, placed on the second 
finger, recorded the HR and peripheral oxygen saturation, and 
a percutaneous PCO2 monitor attached to the inner forearm 
measured the blood CO2 level throughout the procedure. The 
baseline resting PCO2 level was collected immediately before 
the commencement of HV (the zero value in the 20-min HV 
time series). High-amplitude generalized slowing on the EEG 
was an indicator of good physiological response to hyperven-
tilation. The EEG scientist also used a pinwheel as a visual 
indicator, to encourage compliance and increase effort. All 
vEEG data were reviewed by a neurologist.
MyCalmBeat biofeedback assessment
All patients diagnosed with PNES attended a Psychologi-
cal Medicine evaluation—a family assessment [49] and an 
individual assessment, where MyCalmBeat was used to 
document baseline respiratory rate and to assess the children/
adolescents’ ability to slow down their breathing rates to 
upregulate vagal tone. Healthy controls completed the vEEG 
procedure and MyCalmBeat on the same day.
Data analysis
Table 1 lists the measures used for data analysis. A PCO2 
value of <36 mmHg was considered to indicate hypocap-
nia [50, 51]. The term skewed HV-challenge profile was 
used to describe a HV-PCO2 profile that was shifted down 
and that was defined by baseline PCO2 < 36 mmHg, trough 
PCO2 ≤ 20 mmHg, or final PCO2 < 36 mmHg after 15 min 
of recovery. The PCO2 cutoff of ≤20 mmHg was used for the 
trough-PCO2 reading that defined a skewed HV-challenge 
profile because central symptoms are more likely at ≤PCO2 
20 mmHg (range 14–29 mmHg) [52]. A respiratory rate 
above the 75th percentile—≥19 breaths per minute for chil-
dren 8–11 years and ≥21 breaths per minute for adolescents 
12–15 years—was considered to be elevated. A HR above 
the 75th percentile—≥100 bpm for children 8–12 years and 
≥90 bpm for children >12 years—was considered to be ele-
vated. These values for respiratory rate and HR were derived 
from normative reference ranges [53].
A general linear model for multiple analyses was used to 
examine the difference in the HV-challenge curve between 
the PNES group and controls. Chi-square analyses and inde-
pendent t tests were used to calculate differences between 
the PNES group and the merged control group (see below) 
on categorical and continuous variables, respectively. For res-
piratory measures, all control children/adolescents were com-
bined into one group because the three control groups showed 
no significant differences on any measures (see Table 2). For 
HR measures, the PNES group was compared only to healthy 
controls because baseline HR was elevated in both clinical 
control groups (see Table 2).
Results
Clinical characteristics of participants assessed 
for PNES
The clinical cohort consisted of 60 children/ado-
lescents—42 girls and 18 boys, aged 8–17 years 
 Eur Child Adolesc Psychiatry
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Table 1  Description of measures from the hyperventilation (HV) challenge and MyCalmBeat assessments
Measure Description Units
Baseline HR and respiratory rate
 Clinical baseline breathing rate The baseline breathing rate collected during the MyCalmBeat assessment Breath per minute
 Baseline HR The baseline HR value from the start of the HV challenge (zero value on 
Fig. 1)
bpm
Hyperventilation challenge PCO2 measures
 Baseline PCO2 The baseline PCO2 value from the start of HV challenge (zero value on Fig. 1) mmHg
 ∆PCO2 Change in PCO2—the size of the PCO2 drop—calculated as HV baseline PCO2 
minus lowest PCO2 level during HV challenge
mmHg
 Trough PCO2 Lowest PCO2 value during HV challenge mmHg
 Time to trough PCO2 Time from HV baseline PCO2 (zero value) to trough-PCO2 value minutes
 Rate of PCO2 drop Rate of drop from HV baseline PCO2 (zero value) to trough-PCO2 value mmHg/min
 Rate of PCO2 recovery Rate of elevation of PCO2 from trough-PCO2 value during recovery period was 
calculated from trough-PCO2 value during HV challenge to first value in the 
homeostatic range (≥36 mmHg) (if homeostasis was attained) trough-PCO2 
value during HV challenge to final PCO2 value after termination of HV chal-
lenge and 15 min of recovery (if homeostasis was not attained)
mmHg/min
 Final PCO2 Final PCO2 reading after termination of HV challenge and 15 min of recovery mmHg
Other terms used
 Skewed HV profile A HV profile that was shifted down and defined by baseline PCO2 < 36 mmHg, 
trough-PCO2 ≤ 20 mmHg, or final PCO2 < 36 mmHg baseline
Table 2  Study measure comparisons: healthy controls vs. psychiatry controls vs. epilepsy controls
Measure Mean value for psychiatry 
controls (n = 25)
Mean value for healthy 
controls (n = 17)
Mean value for epilepsy 
controls (n = 8)
t (p value) psychiatry vs. 
healthy controls epilepsy 
vs. healthy controls
Baseline HR and respiratory rate
 Baseline HR (bpm) 87.16 77.24 86.50 −2.412 (0.021)
−1.870 (0.074)
 Clinical baseline breathing rate 
(breaths per minute)
18.00 range (8–24) 19.71 range (8–31) Missing data 1.628 (0.116)
–
Hyperventilation challenge PCO2 measures
 Baseline PCO2 (mmHg) 41.20 41.06 41.13 −0.130 (0.897)
−0.042 (0.967)
 ∆PCO2 (mmHg) 13.88 15.47 17.00 1.397 (0.170)
−0.944 (0.355)
 Trough-PCO2 (mmHg) 27.32 25.59 25.00 −1.435 (0.159)
0.485 (0.632)
 Time to trough PCO2 (min) 5.16 5.53 4.88 1.469 (0.150)
1.674 (0.108)
 Rate of PCO2 drop (mmHg/
min)
2.76 2.89 2.83 0.451 (0.654)
−1.905 (p = .069)
Recovery measures
 Rate of PCO2 recovery (mmHg/
min)
4.00 5.56 3.63 1.482 (0.153)
1.302 (0.206)
 Final PCO2 (mmHg) 41.26 43.65 44.13 −1.012 (0.318)
−1.641 (0.114)
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[mean = 13.45; standard deviation (SD) = 2.61]—under-
going vEEG for assessment of PNES. Of the 60 patients, 
7 presented with a clinical diagnosis of HV at referral.
The time from onset of PNES ranged from one day to 
48 months (median = 2 months). In 28 cases (47%) the 
PNES presented alongside other functional neurological 
symptoms; in 10 cases (17%) the PNES presented along-
side chronic pain; and in 22 cases (36.66%) the PNES 
were the primary presenting symptom. PNES semiology 
included the following: movements (rhythmic, thrashing/
kicking, flexion/extension) (n = 15); syncopal-like events 
alone (n = 11); visual blackout, loss of vision, or changes 
in consciousness associated with head dropping (n = 8); 
prolonged periods of unresponsiveness (n = 2); sensory 
experiences (n = 2); changes in responsiveness followed 
by amnesia lasting days or weeks (loss of memory of 
self or parents) (n = 2); staring episodes (n = 1); both 
movements and syncopal-like events (n = 17); and move-
ments, syncopal-like events, and long periods of unre-
sponsiveness (n = 2).
A third of children/adolescents (20/60; 33.33%) 
suffered from comorbid neurological conditions (see 
Table 3). All families reported antecedent stressors 
(range, 1–12; mean = 4.63; median = 4): an illness event 
(accident, infection, or diagnosis or relapse of a chronic 
illness) (30/60; 50%); family conflict (26/60; 43%); 
maternal mental illness (typically anxiety or depression) 
(26/60; 43%); being bullied (23/60; 38%); loss due to 
separation (21/60; 35%); paternal mental illness (16/60; 
27%); loss due to death (13/60; 22%); or exposure to 
domestic violence (12/60; 20%). Maltreatment was less 
common: sexual abuse (8/60; 13%); physical abuse (7/60; 
12%); or neglect (7/60; 12%). Comorbid motor-sensory 
conversion symptoms, comorbid pain, other nonspecific 
somatic symptoms, and comorbid psychiatric conditions 
diagnosed using DSM-IV-TR criteria were common and 
are documented in Table 3.
Control group
The control group consisted of 50 children/ado-
lescents—27 girls and 23 boys, aged 7–17 years 
(mean = 13.63; SD = 2.50). Seventeen children were 
from control group 1 (healthy controls), 25 from control 
group 2 (inpatient psychiatry controls: 8 with other func-
tional neurological symptoms; 6 with somatoform pain; 
and 11 with depression, self-harm, or behavioral symp-
toms), and 8 from control group 3 (epilepsy controls). 
There were no significant differences between patients 
and controls regarding age [t(108) = −0.183; p = .855] 
and sex (χ2 = 2.99; p = .08).
Table 3  Comorbid neurological, medical and psychiatric diagnoses 
and comorbid non-specific somatic symptoms
n %
Current comorbid neurological condition
 Epileptic seizures (one was part of a congenital 
syndrome, see below)
7 11.67
 Congenital condition with neurological manifesta-
tions (neurofibromatosis Type 1 with hydrocepha-
lus, epilepsy, and ocular gliomas; chromosome 
deletion 8 with spontaneous intraventricular 
bleeds, hydrocephalus, and ventriculo-peritoneal 
shunting procedures)
2 3.33
 Left cerebral atrophy of unknown cause (unchang-
ing over time)
1 1.67
 Cerebral palsy 1 1.67
 Hereditary angioedema 1 1.67
 Tuberous sclerosis 1 1.67
 Cerebellopontine angle cavernoma 1 1.67
 Migraine (one child’s migraines were accompanied 
by hemiplegia)
2 3.33
 Developmental delay 2 3.33
Past history of a neurological insult to the central nervous system
 Past history of viral meningitis 2 3.33
 Past history of chemotherapy 1 1.67
Other conditions or vulnerabilities
 Type 1 diabetes 1 1.67
 Past history of Bell’s palsy 1 1.67
 Hypermobility 4 6.67
 Fainting secondary to orthostatic stress (2 girls, 1 
boy)
3 5
 Postural tachycardia syndrome (POTTS) 5 8.33
 Borderline IQ 8 13.33
Comorbid psychological conditions and somatic 
symptoms
 Motor-sensory conversion symptoms 32 53.33
 Anxiety disorder (excluding PTSD and panic 
disorder)
22 36.67
 PTSD 7 11.67
 Panic disorder 7 11.67
 Depression 10 16.67
 Dissociative symptoms (loss of memory or capacity 
to recognize family members)
18 30
 Behavioral disorder 3 5
 Eating disorder 1 1.67
 Comorbid pain 41 68.33
 Disturbed sleep 23 38.33
 Any nonspecific somatic symptom (excluding pain) 53 88.33
 Dizziness 40 66.67
 Breathlessness 33 55
 Nausea 25 41.67
 Fatigue 25 41.67
 Heart pounding 20 33.33
 Pins and needles 11 18.33
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Missing data
Baseline respiratory rates recorded at the beginning of the 
MyCalmBeat assessment were available for 52/60 chil-
dren/adolescents with PNES and for 28/50 controls. HV-
challenge data were available for all participants but were 
incomplete for 14 children/adolescents with PNES—miss-
ing the end part of the recovery period—because the proce-
dure had been terminated early.
Baseline respiratory rates at MyCalmBeat assessment
Patients with PNES had higher baseline respira-
tory rates than controls [patients: mean = 24.62; 
SD = 8.58; median = 24.50; range 8–50 bpm vs. con-
trols: mean = 19.71; SD = 4.62; median = 20; range 
8–31 bpm (t(77.995) = 3.323, p = .001)] (see Table 4). 
Using clinical reference ranges, an elevated baseline res-
piratory rate (above the 75th percentile) was documented 
in 36/52 (69%) patients with PNES (20–50 breaths per 
minute; mean = 28.61; SD = 7.121; median = 26.50) 
and 11/28 (39%) controls (21–31 breaths per min-
ute; mean = 23.73; SD = 2.901; median = 23.00) 
(χ2 = 6.7343; df = 1; p = .009).
Baseline HR at hyperventilation‑challenge assessment
In line with findings from a previous study [10], patients 
with PNES had higher baseline HR than healthy controls 
(patients: mean = 90.97; SD = 12.78; median = 91.00; range 
64–127 bpm vs. healthy controls: mean = 77.24; SD = 11.23; 
median = 79.00; range 55–97 bpm [t(75) = 4.008, p < .001)] 
(see Table 4). Using clinical reference ranges, an elevated 
baseline HR (above the 75th percentile) was documented in 
29/60 (48%) patients with PNES and 1/17 (6%) healthy con-
trols) (χ2 = 10.04; df = 1; p = .002).
Relationship between respiration rate and HR
Increases in respiratory rate after the instruction to hyper-
ventilate were followed by an increase in HR in both 
patients (mean change = 21 bpm) and controls (mean 
change = 23 bpm) [t(108) = −0.79, p = .43].
Arterial PCO2 during the HV challenge of the vEEG 
test
The PNES group (in red) and control group (in blue) 
(Fig. 1) showed clear differences in the PCO2 response to 
Table 4  Between-group differences in respiratory and heart measures during the hyperventilation challenge
a Analyses with HR were done between the PNES group and healthy controls because the other clinical groups also showed elevated baseline 
HR (see Table 3)
Measure PNES group mean value (n = 60) Control group mean value 
(n = 50)
t p Cohen’s d effect size
Baseline HR and respiratory rate
 Baseline HR (bpm)a 90.97 77.24 (n = 17, healthy controls) 4.008 <.001 0.96
 Clinical baseline breathing rate 
(breaths per minute)
24.62 (n = 52 due to missing 
data)
19.71 (n = 28 due to missing 
data)
3.323 .001 0.64
Hyperventilation challenge PCO2 measures
 Baseline PCO2 (mmHg) 36.97 41.14 −5.53 <.001 1.07
 ∆PCO2 (mmHg) 13.14 14.92 −2.07 .041 0.40
 Trough-PCO2 (mmHg) 23.85 26.36 −3.09 .003 0.59
 Time to trough PCO2 (min) 5.13 5.24 .552 .582 0.11
 Rate of PCO2 drop (mmHg/min) 2.65 2.98 −1.65 .102 0.32
Recovery measures
n = 51 n = 48
 Rate of PCO2 recovery (mmHg/
min)
1.94 3.18 −4.09 <.001 0.91
n = 47 n = 50
 Final PCO2 (mmHg) 36.21 42.36 −6.37 <.001 1.40
Other
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the HV challenge [F(1, 94) = 34.26; p < .001; partial eta 
square = 0.267]. The HV-challenge profile of the PNES 
group was shifted downward (away from homeostatic 
range) and characterized by a significantly lower baseline 
PCO2, lower trough PCO2, slower rate of PCO2 recovery, 
and lower final PCO2. Whereas the time to trough PCO2 
and the rate of PCO2 drop were the same as in controls, 
the actual ∆PCO2 with hyperventilation was smaller (see 
Table 4). Further analysis showed that 28/60 PNES patients 
(47%) showed a skewed HV-challenge profile—defined as 
a baseline PCO2 < 36 mmHg, trough PCO2 ≤ 20 mmHg, 
or failure of recovery back to homeostasis—compared 
to only 4/50 (8%) controls (χ2 = 19.77; df = 1; p < .001) 
(see Table 5). During the HV challenge, symptoms of cer-
ebral hypoxia—dizziness, head dropping, staring, visual 
changes, or changes in consciousness—were almost five 
times more frequent in patients with PNES (23/60) than in 
controls (4/50) (χ2 = 13.55; df = 1; p < .001).
Observation of PNES episodes during treatment admis-
sions showed that in 32 of the 60 patients, paroxysmal 
increases in ventilation—probable HV—occurred imme-
diately prior to PNES episodes. The PCO2 response to HV 
challenge of this “HV-induced PNES” subgroup is shown 
in black on Fig. 1. The average profile of this subgroup 
of patients was shifted even more downward (away from 
homeostatic range) than in the PNES group as a whole.
Discussion
The PNES Hyperventilation Study used respiratory meas-
ures—baseline respiratory rate at clinical assessment and 
percutaneous CO2 monitoring during the hyperventilation 
component of routine vEEG—to assess motor readiness 
and CO2 regulation in children/adolescents with PNES and 
in controls. Baseline HR was also documented. As a group, 
patients with PNES had elevated baseline respiratory rates, 
elevated baseline HR, and skewed HV-challenge profiles, 
with significantly lower levels of arterial CO2 at all time-
points of the HV challenge. Symptoms of cerebral hypoxia 
were also almost five times more frequent in patients with 
PNES than in controls during the HV challenge. The study 
findings suggest patients presented in a state of readiness-
for-action characterized by high arousal coupled with acti-
vation of the respiratory motor system and increases in 
ventilation. Their CO2 profiles during the HV challenge 
were shifted downward away from the homeostatic range, 
suggesting that excessive activation of the respiratory 
motor system, coupled with difficulties in regulating CO2, 
may contribute to the functional neural mechanisms that 
underpin PNES.
Although motor activity (mediated by the skeletomo-
tor system) and sympathetic arousal (mediated by the vis-
ceromotor system) involve separate neural systems, they 
are interrelated and activated in a coordinated manner. 
Activation of the motor system (including its ventilatory 
component) is always coupled with sympathetic arousal, 
and sympathetic arousal is always coupled with activa-
tion of the motor system (at least an increase in muscle 
tone) [54–56]. This close interconnection between motor 
activation, including ventilation, and sympathetic arousal 
is a product of brain structure and function; the cortical 
areas involved in preparing and generating motor (skel-
etomotor) outputs overlap with those from which sym-
pathetic (visceromotor) outputs originate [56]. Motor 
activity, including states of motor readiness and motor 
preparation, are accompanied by concurrent changes in 
ventilation and sympathetic output that match the meta-
bolic demands of the movement. In the face of perceived 
threat, increased ventilation and a correlative increase 
in sympathetic arousal are part of the body’s prepara-
tion for action [54, 55]. In our study, however, we found 
that children/adolescents with PNES had low baseline 
PCO2 and failure of PCO2 recovery back to homeosta-
sis following the HV challenge. These findings indi-
cate overreactivity and dysregulation of the finely tuned 
interconnections between motor activity and sympa-
thetic arousal. This result matches, in part, the results of 
our previous studies, in which all children/adolescents 
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HV-induced PNES
Fig. 1  Hyperventilation profiles in children and adolescents assessed 
for PNES and in controls. The shaded blue area depicts the homeo-
static range for arterial CO2. The top blue line depicts controls. Con-
trols showed a clear pattern of PCO2 changes during the HV task: a 
baseline PCO2 within the homeostatic range, a steep drop in PCO2 
during HV, and a prompt return to homeostasis during recovery. The 
middle red line depicts the 60 children and adolescents with PNES 
who participated in the study. Children and adolescents with PNES 
showed a downwardly skewed HV-challenge profile suggesting dif-
ficulties with PCO2 regulation. The bottom black line depicts the sub-
group of 32 children and adolescents who whose PNES were typi-
cally preceded by—“triggered by”—HV
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PNES subgroup—showed increased arousal and motor 
readiness to emotion stimuli. A striking difference in the 
PNES subgroup, however, is their excessive activation of 
the respiratory motor system and the associated dysregu-
lation of CO2 control, which may well contribute to their 
propensity for PNES.
As noted in the introduction, neurophysiological studies 
show that patients with PNES demonstrate altered prop-
erties in brain networks—changes (both decreases and 
increases) in the relationship between cortical brain regions 
that normally function together [5, 16–19, 57–59]—result-
ing in functional disruptions in both the brain’s horizontal 
integration (between cortical regions) and its vertical inte-
gration (between cortical and subcortical regions). These 
functional disruptions are likely to weaken executive con-
trol over motor areas and to prioritize reflexive control of 
behaviors, thereby enabling release or activation of prewired 
autonomous motor programs [4]—presumably those that 
are represented at the level of the basal ganglia, midbrain, 
and brainstem.
We suggest that in children/adolescents, HV may con-
tribute to functional brain disruptions and, via two differ-
ent mechanisms, to a propensity to PNES. First, because 
of the close coupling between respiration and sympathetic 
arousal, HV-induced increases in cortical arousal could 
trigger PNES by disrupting cortical executive control over 
the motor cortex and cortico–basal ganglia–thalamocor-
tical loops. Since children/adolescents with PNES show 
increased baseline autonomic and cortical arousal [10, 13, 
15], even minor elevations in arousal mediated by HV could 
disrupt cortical control and serve to disrupt cortical integra-
tion [60–62] and trigger PNES. Second, if HV continues 
beyond the excitatory stage into the hypoxic stage, then 
hypoxia-related impairments in the cortex and basal ganglia 
[63] will likewise contribute to dysfunction in top–down 
control mechanisms within the motor system and to disrup-
tions in the brain’s vertical integration. Because the basal 
ganglia and brain stem mediate changes in muscle tone and 
consciousness [64], a subset of PNES patients with HV-
induced hypoxia will experience changes in consciousness 
and losses of muscle tone.
Contrary to our original hypothesis, we found no signifi-
cant differences between patients with PNES and controls 
in time to lowest PCO2 levels and in rates of PCO2 drop, 
and the PNES group had a smaller, not greater, ∆PCO2. 
These findings are consistent with a downwardly skewed 
HV-challenge profile, where the ∆PCO2 was smaller 
because patients had decreased reserves and reached a floor 
effect, as evidenced by central symptoms of HV-induced 
hypoxia. Son et al. [65] likewise found that ∆PCO2 was not 
useful in the assessment of EEG slowing (and of the associ-
ated cerebral dysfunction) in child/adolescent patients.
All the PNES patients in this study reported stress-
ors prior to the onset of PNES—illness, injury, emotional 
distress secondary to adverse life events, or psychological 
trauma. Not all stressors involved psychological distress per 
se. These findings highlight that from the perspective of the 
body, the types of stressors that effect brain-body stress sys-
tems and that predispose children/adolescents to PNES go 
well beyond those that are subsumed under the umbrella of 
“psychogenic”. From the perspective of the body, various 
stressors—pain, inflammation, and disruptions of the circa-
dian cycle, as well as psychological stress and psychological 
trauma—may function to activate a sensitized, highly reac-
tive stress system and to change functional organization of 
the brain [43, 60, 61, 66–70], with PNES being an unwanted 
by-product of the body’s response to threat.
This study was carried out as part of our busy routine 
clinical practice. It has a number of limitations. First, 
although transcutaneous measures of PCO2 correlate well 
with arterial blood levels, the diffusion of CO2 from the 
blood to the skin is slow; changes in arterial PCO2 are 
registered with a delay of 1–2 min, and sharp changes are 
blunted [71]. Second, skewed HV-challenge profiles—and 
trough-PCO2 levels, in particular—in combination with 
EEG slowing are an approximate measure of HV-induced 
neurophysiological changes. In future studies, more direct 
measures of vasoconstriction/cerebral artery blood flow 
(via Doppler ultrasound) would help to clarify underly-
ing neurophysiological mechanisms, as would measuring 
changes in patterns of brain oxygenation (via functional 
magnetic resonance imaging). Third, no simple, direct 
measures of cortical arousal are currently available. Tech-
niques to measure such changes on a second-to-second 
basis would help to clarify underlying neurophysiologi-
cal mechanisms. Fourth, respiratory rates were measured 
at clinical assessment but not during the vEEG procedure. 
That said, arterial CO2 is the gold standard for measuring 
Table 5  Abnormal HV profiles in participants with PNES vs. controls
Categorical variable PNES group n Control group n Chi squared (χ2) p value
Skewed HV profile (skew in any of the three components below) 26/60 4/50 19.77 <.001
Hypocapnia at baseline (PCO2 < 36 mmHg) 21/60 3/50 13.45 <.001
Lowest PCO2 ≤ 20 mmHg 16/60 2/50 10.24 .001
Failure of recovery to homeostasis, or final PCO2 <36 mmHg 19/47 1/50 21.86 <.001
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HV. Elevated respiratory rates alone (without considera-
tion of tidal volume) can flag the possibility of HV but do 
not measure it directly. Finally, it would have been useful 
to collect data about the contribution of disturbed sleep 
and the menstrual cycle (in 27/60 postpubertal girls) to the 
upregulation of the stress system [72, 73].
Despite limitations, this study contributes to current 
research efforts to identify the biological mechanisms that 
underpin PNES. The study has important implications for 
assessing and treating PNES in paediatric practice. Chil-
dren/adolescents with PNES present in a state of increased 
baseline arousal. In a subset, increased arousal is coupled 
with excessive activation and reactivity of the motor res-
piratory system, and in these children/adolescents, PNES 
can be preceded and triggered by paroxysmal increases in 
arousal coupled with HV. Identifying patients in whom HV 
appears to trigger PNES is important because the major-
ity of child/adolescent patients are able to utilize breathing 
interventions to slow their breathing, downregulate arousal, 
and avert PNES episodes. Once the PNES have come under 
control, the children, adolescents, and families are better 
placed to address the psychological or physiological threats 
that triggered their PNES in the first place.
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